Video summary

CSU Researchers Need Dogs In Cancer Vaccine Study

Main summary

Key takeaways

Science and Nature

Scientific concepts, discoveries, or nature phenomena

  • Cancer prevention via vaccination (vaccine approach to stop cancer development) The study tests whether a vaccine can target proteins on the surface of cancer cells before they become established, with the goal of preventing cancer from developing.

  • Translational oncology: moving from mouse models to dogs and potentially humans The vaccine concept has shown promise in mice, but the video emphasizes that effectiveness in humans is uncertain. Dogs are discussed as a potentially more predictive bridge.

  • Why canine models may predict human cancer risk

    • Similarity of cancer types between dogs and people
    • Shared environmental exposures (dogs and people “breathe the same air,” “drink the same water,” etc.)
    • Similarity of immune systems between dogs and humans These factors are presented as reasons that positive canine results could support the likelihood of benefit in humans.

  • Study immune response and safety signals

    • Preliminary findings indicate the vaccine stimulates the intended immune response
    • No concerning side effects have been observed so far (as of the interview)

Methodology / study design (as described)

  • Target population: Mixed-breed dogs and specific breeds at higher-than-average risk of death due to cancer
  • Recruitment & screening:
    • Initial thorough health screening including:
      • Blood work
      • Chest X-rays
      • Other tests to confirm dogs are healthy
  • Age range: Approximately 6 to 11 years
  • Randomization & blinding:
    • Dogs are randomly assigned to either:
      • the candidate vaccine, or
      • a placebo (“phony vaccine”)
    • Completely blinded (owners/study personnel do not know group assignments)
  • Vaccination schedule:
    • Initial series of four vaccines
  • Follow-up / monitoring:
    • Twice yearly exams by a cancer specialist to check for evidence of cancer (e.g., new lumps/bumps)
    • Once yearly comprehensive geriatric blood panels for overall health monitoring
  • If a dog develops cancer:
    • A financial incentive at CSU to help defray treatment costs
  • Enrollment status mentioned:
    • About 530 of 800 dogs enrolled nationwide (as of the interview)
    • Still actively seeking participants

Featured researchers / sources

  • Dr. Doug Tham — Director of Clinical Research, CSU Flint Animal Cancer Center
  • Dr. Stephen Johnston — Basic scientist and inventor at Arizona State University (mentioned as originating the protein-targeting concept)

Original video